/newsroom/taxonomy/term/7535/all en /newsroom/channels/news/treatment-dry-eye-disease-based-mcgill-research-257072 <p><span>The discovery that tavilermide聽 induces the production of mucin, a crucial lubricant in tears, offers hope of relief to people who suffer from chronic dry eye disease. The invention and the development of a drug based on this small molecule was made by the team of Dr. H. Uri Saragovi, Senior Investigator at the Lady Davis Institute (LDI) at the Jewish General Hospital and Professor of Pharmacology at 黑料不打烊 University.</span></p> Mon, 30 Nov 2015 21:35:16 +0000 nima.adibpour@mail.mcgill.ca 24961 at /newsroom